Jundishapur Journal of Microbiology

Published by: Kowsar

Pseudomonas aeruginosa Recombinant Flagellin Induced Poly-Isotypic Humoral Immune Responses in the Balb/C Mice

Arezoo Shajiei 1 , 2 , Arezoo Rezaei Malal 3 , Ghorbanali Shahabi 3 , Ramin Farhoudi 4 , Sobhan Faezi 5 , Majid Tebianian 6 , Nooshin Sohrabi 7 and Mehdi Mahdavi 1 , *
Authors Information
1 Department of Virology, Pasteur Institute of Iran, Tehran, IR Iran
2 Molecular Pathology Laboratory, Ghaem Medical Center, Mashhad University of Medical sciences, Mashhad, IR Iran
3 Department of Immunology, Cellular and Molecular Research Center, Shahrekord University, Shahrekord, IR Iran
4 Department of Laboratory Animal Science, Pasteur Institute of Iran, Tehran, IR Iran
5 Department of Bacteriology, Pasteur Institute of Iran, Tehran, IR Iran
6 Department of Biotechnology, Razi Vaccine and Serum Research Institute, Karaj, IR Iran
7 Department of Biology, Payam Noor University, Pardis, Tehran, IR Iran
Article information
  • Jundishapur Journal of Microbiology: September 01, 2013, 6 (7); e6760
  • Published Online: September 10, 2013
  • Article Type: Research Article
  • Received: June 11, 2012
  • Revised: September 19, 2012
  • Accepted: October 24, 2012
  • DOI: 10.5812/jjm.6760

To Cite: Shajiei A, Rezaei Malal A, Shahabi G, Farhoudi R, Faezi S, et al. Pseudomonas aeruginosa Recombinant Flagellin Induced Poly-Isotypic Humoral Immune Responses in the Balb/C Mice, Jundishapur J Microbiol. 2013 ; 6(7):e6760. doi: 10.5812/jjm.6760.

Abstract
Copyright © 2013, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Pier G. Application of vaccine technology to prevention of Pseudomonas aeruginosa infections. Expert Rev Vaccines. 2005; 4(5): 645-56[DOI][PubMed]
  • 2. Erol S, Altoparlak U, Akcay MN, Celebi F, Parlak M. Changes of microbial flora and wound colonization in burned patients. Burns. 2004; 30(4): 357-61[DOI][PubMed]
  • 3. Ramos HC, Rumbo M, Sirard JC. Bacterial flagellins: mediators of pathogenicity and host immune responses in mucosa. Trends Microbiol. 2004; 12(11): 509-17[DOI][PubMed]
  • 4. Winstanley C, Coulson MA, Wepner B, Morgan JA, Hart CA. Flagellin gene and protein variation amongst clinical isolates of Pseudomonas aeruginosa. Microbiology. 1996; 142 ( Pt 8): 2145-51[PubMed]
  • 5. McSorley SJ, Ehst BD, Yu Y, Gewirtz AT. Bacterial flagellin is an effective adjuvant for CD4+ T cells in vivo. J Immunol. 2002; 169(7): 3914-9[PubMed]
  • 6. Sanders CJ, Yu Y, Moore DA, 3rd, Williams IR, Gewirtz AT. Humoral immune response to flagellin requires T cells and activation of innate immunity. J Immunol. 2006; 177(5): 2810-8[PubMed]
  • 7. Higgins SC, Mills KH. TLR, NLR Agonists, and Other Immune Modulators as Infectious Disease Vaccine Adjuvants. Curr Infect Dis Rep. 2010; 12(1): 4-12[DOI][PubMed]
  • 8. Munster AndrewM, Leary AnneG. Cell-mediated immune responses to pseudomonas aeruginosa. Am J Surg. 1977; 133(6): 710-2[DOI]
  • 9. Cripps AW, Dunkley ML, Clancy RL, Kyd J. Pulmonary immunity to Pseudomonas aeruginosa. Immunol Cell Biol. 1995; 73(5): 418-24[DOI][PubMed]
  • 10. Johansen HK, Hougen HP, Rygaard J, Hoiby N. Interferon-gamma (IFN-gamma) treatment decreases the inflammatory response in chronic Pseudomonas aeruginosa pneumonia in rats. Clin Exp Immunol. 1996; 103(2): 212-8[PubMed]
  • 11. Honko AN, Sriranganathan N, Lees CJ, Mizel SB. Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis. Infect Immun. 2006; 74(2): 1113-20[DOI][PubMed]
  • 12. Singh M, O'Hagan DT. Recent advances in vaccine adjuvants. Pharm Res. 2002; 19(6): 715-28[PubMed]
  • 13. Mahdavi M, Ebtekar M, Khorram Khorshid HR, Azadmanesh K, Hartoonian C, Hassan ZM. ELISPOT analysis of a new CTL based DNA vaccine for HIV-1 using GM-CSF in DNA prime/peptide boost strategy: GM-CSF induced long-lived memory responses. Immunol Lett. 2011; 140(1-2): 14-20[DOI][PubMed]
  • 14. Campodonico VL, Llosa NJ, Grout M, Doring G, Maira-Litran T, Pier GB. Evaluation of flagella and flagellin of Pseudomonas aeruginosa as vaccines. Infect Immun. 2010; 78(2): 746-55[DOI][PubMed]
  • 15. Doring G, Pier GB. Vaccines and immunotherapy against Pseudomonas aeruginosa. Vaccine. 2008; 26(8): 1011-24[DOI][PubMed]
  • 16. Goudarzi G, Sattari M, Roudkenar MH, Montajabi-Niyat M, Zavaran-Hosseini A, Mosavi-Hosseini K. Cloning, expression, purification, and characterization of recombinant flagellin isolated from Pseudomonas aeruginosa. Biotechnol Lett. 2009; 31(9): 1353-60[DOI][PubMed]
  • 17. Faezi S, Sattari M, Mahdavi M, Roudkenar MH. Passive immunisation against Pseudomonas aeruginosa recombinant flagellin in an experimental model of burn wound sepsis. Burns. 2011; 37(5): 865-72[DOI][PubMed]
  • 18. Sadikot RT, Blackwell TS, Christman JW, Prince AS. Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med. 2005; 171(11): 1209-23[DOI][PubMed]
  • 19. Jang SI, Lillehoj HS, Lee SH, Lee KW, Park MS, Bauchan GR, et al. Immunoenhancing effects of Montanide ISA oil-based adjuvants on recombinant coccidia antigen vaccination against Eimeria acervulina infection. Vet Parasitol. 2010; 172(3-4): 221-8[DOI][PubMed]
  • 20. Kyd JM, Dunkley ML, Cripps AW. Enhanced respiratory clearance of nontypeable Haemophilus influenzae following mucosal immunization with P6 in a rat model. Infect Immun. 1995; 63(8): 2931-40[PubMed]
  • 21. Saha S, Takeshita F, Matsuda T, Jounai N, Kobiyama K, Matsumoto T, et al. Blocking of the TLR5 activation domain hampers protective potential of flagellin DNA vaccine. J Immunol. 2007; 179(2): 1147-54[PubMed]
  • 22. Jiao XD, Hu YH, Sun L. Dissection and localization of the immunostimulating domain of Edwardsiella tarda FliC. Vaccine. 2010; 28(34): 5635-40[DOI][PubMed]
  • 23. Smith KD, Andersen-Nissen E, Hayashi F, Strobe K, Bergman MA, Barrett SL, et al. Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nat Immunol. 2003; 4(12): 1247-53[DOI][PubMed]
  • 24. Ben-Yedidia T, Marcus H, Reisner Y, Arnon R. Intranasal administration of peptide vaccine protects human/mouse radiation chimera from influenza infection. Int Immunol. 1999; 11(7): 1043-51[PubMed]
  • 25. Honko AN, Mizel SB. Mucosal administration of flagellin induces innate immunity in the mouse lung. Infect Immun. 2004; 72(11): 6676-9[DOI][PubMed]
  • 26. Verma A, Arora SK, Kuravi SK, Ramphal R. Roles of specific amino acids in the N terminus of Pseudomonas aeruginosa flagellin and of flagellin glycosylation in the innate immune response. Infect Immun. 2005; 73(12): 8237-46[DOI][PubMed]
  • 27. Buret A, Dunkley ML, Pang G, Clancy RL, Cripps AW. Pulmonary immunity to Pseudomonas aeruginosa in intestinally immunized rats roles of alveolar macrophages, tumor necrosis factor alpha, and interleukin-1 alpha. Infect Immun. 1994; 62(12): 5335-43[PubMed]
  • 28. Vassilieva EV, Wang BZ, Vzorov AN, Wang L, Wang YC, Bozja J, et al. Enhanced mucosal immune responses to HIV virus-like particles containing a membrane-anchored adjuvant. MBio. 2011; 2(1)-10[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments